Can high-sensitivity troponin values at emergency department presentation help predict MI and 30-day outcomes?

BEEM Bottom Line

Why is this study important?

Biomarker companies have refined troponin I and T tests to be able to detect very low levels in the blood. This study found that these tests are highly sensitive for detecting either Type 1 or Type 2 myocardial infarction (MI) and may predict 30-day outcomes in patients presenting to the emergency department (ED) with suspected acute coronary syndrome.

Which, if any, threats to validity are most likely to have an impact on the results and how?

Thank you for your interest in the BEEM Journal!

To read the rest of this article or to access the entire collection of BEEM Critical Appraisals, please purchase a subscription at the link below.

If you would like a pre-view, click here to view some sample articles

Premium Content Available Through Subscription

BEEM is a knowledge translation project which aims to extract the most recent, EM relevant, and valid evidence from the volumes of available medical research and deliver it to EM practitioners in an easily consumable format to help guide their clinical practice. This valuable distilled information provided by BEEM is available through BEEM's accredited CME courses or through our online journal.

A BEEM Journal Subscription will provide you with unlimited access to our entire collection of Critical Appraisals for 1 year.